Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2074-2081
© 1997 American Heart Association, Inc.
Articles |
Homocysteine as a Risk Factor for Vascular Disease
Enhanced Collagen Production and Accumulation by Smooth Muscle Cells
From the Department of Cell Biology, Research Institute, Cleveland Clinic Foundation, Ohio. Drs Majors and Pezacka are now affiliated with the Department of Human Genetics, Allegheny University of the Health Sciences, Pittsburgh, Pa.
Abstract An increased plasma homocysteine level is an independent risk factor for vascular disease. However, the pathological mechanisms by which homocysteine promotes atherosclerosis are not yet clearly defined. Arterial smooth muscle cells cultured in the presence of homocysteine grew to a higher density and produced and accumulated collagen at levels significantly above control values. Homocysteine concentrations as low as 50 µmol/L significantly increased both cell density and collagen production. Cell density increased by as much as 43% in homocysteine-treated cultures. Homocysteine increased collagen production in a dose-dependent manner. Smooth muscle cells treated with homocysteine at concentrations observed in patients with hyperhomocysteinemia had collagen synthesis rates as high as 214% of control values. Likewise, collagen accumulation in the cell layer was nearly doubled in homocysteine-treated cultures. Addition of aquacobalamin to homocysteine-treated cultures controlled the increase in smooth muscle cell proliferation and collagen production. These results indicate a cellular mechanism for the atherogenicity of homocysteine and provide insight into a potential preventive treatment.
Key Words: collagen • atherosclerosis • homocysteine • smooth muscle cell • extracellular matrix
This article has been cited by other articles:
 |
|
 |
|
  E. M. Schwartzfarb and P. Romanelli Hyperhomocysteinemia and Lower Extremity Wounds International Journal of Lower Extremity Wounds, September 1, 2008; 7(3): 126 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Jiang, J. Jiang, J. Xiong, J. Cao, N. Li, G. Li, and S. Wang Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes J. Exp. Biol., March 15, 2008; 211(6): 911 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zittan, M. Preis, I. Asmir, A. Cassel, N. Lindenfeld, S. Alroy, D. A. Halon, B. S. Lewis, A. Shiran, J. E. Schliamser, et al. High frequency of vitamin B12 deficiency in asymptomatic individuals homozygous to MTHFR C677T mutation is associated with endothelial dysfunction and homocysteinemia Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H860 - H865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Mullick, U. B. Zaid, C. N. Athanassious, S. R. Lentz, J. C. Rutledge, and J. D. Symons Hyperhomocysteinemia increases arterial permeability and stiffness in mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1349 - R1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Patterson, P R Flatt, L Brennan, P Newsholme, and N H McClenaghan Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic {beta}-cell glucose metabolism and insulin secretion. J. Endocrinol., May 1, 2006; 189(2): 301 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. De Luca, H. Suryapranata, G. Gregorio, H. Lange, and M. Chiariello Homocysteine and Its Effects on In-Stent Restenosis Circulation, November 8, 2005; 112(19): e307 - e311. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Ganji and M. R Kafai Frequent consumption of milk, yogurt, cold breakfast cereals, peppers, and cruciferous vegetables and intakes of dietary folate and riboflavin but not vitamins B-12 and B-6 are inversely associated with serum total homocysteine concentrations in the US population Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1500 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lange, H. Suryapranata, G. De Luca, C. Borner, J. Dille, K. Kallmayer, M. N. Pasalary, E. Scherer, and J.-H. E. Dambrink Folate Therapy and In-Stent Restenosis after Coronary Stenting N. Engl. J. Med., June 24, 2004; 350(26): 2673 - 2681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sundstrom, L. Sullivan, J. Selhub, E. J Benjamin, R. B D'Agostino, P. F Jacques, I. H Rosenberg, D. Levy, P. W.F Wilson, and R. S Vasan Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study Eur. Heart J., March 2, 2004; 25(6): 523 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Soinio, J. Marniemi, M. Laakso, S. Lehto, and T. Ronnemaa Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus Ann Intern Med, January 20, 2004; 140(2): 94 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rodrigo, W. Passalacqua, J. Araya, M. Orellana, and G. Rivera Homocysteine and Essential Hypertension J. Clin. Pharmacol., December 1, 2003; 43(12): 1299 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Majors, R. C. Austin, C. A. de la Motte, R. E. Pyeritz, V. C. Hascall, S. P. Kessler, G. Sen, and S. A. Strong Endoplasmic Reticulum Stress Induces Hyaluronan Deposition and Leukocyte Adhesion J. Biol. Chem., November 21, 2003; 278(47): 47223 - 47231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Deussen Adenosine--the missing link to understanding homocysteine pathogenicity or more smoke on the horizon? Cardiovasc Res, August 1, 2003; 59(2): 259 - 261. [Full Text] [PDF]
|
|
|
|
|
|
J. Joseph, L. Joseph, N. S. Shekhawat, S. Devi, J. Wang, R. B. Melchert, M. Hauer-Jensen, and R. H. Kennedy Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H679 - H686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Noga, L. M. Stead, Y. Zhao, M. E. Brosnan, J. T. Brosnan, and D. E. Vance Plasma Homocysteine Is Regulated by Phospholipid Methylation J. Biol. Chem., February 14, 2003; 278(8): 5952 - 5955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Joseph, A. Washington, L. Joseph, L. Koehler, L. M. Fink, M. Hauer-Jensen, and R. H. Kennedy Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2567 - H2574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schnyder, Y. Flammer, M. Roffi, R. Pin, and O. M. Hess Plasma homocysteine levels and late outcome after coronary angioplasty J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1769 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hunt and S. C. Tyagi Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1073 - C1079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schnyder, M. Roffi, Y. Flammer, R. Pin, and O. M. Hess Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial JAMA, August 28, 2002; 288(8): 973 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schnyder, M. Roffi, Y. Flammer, R. Pin, and O.M. Hess Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty Eur. Heart J., May 1, 2002; 23(9): 726 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, X. Jiang, F. Yang, G. B. Chapman, W. Durante, N. E. S. Sibinga, and A. I. Schafer Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition Blood, February 1, 2002; 99(3): 939 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schnyder, M. Roffi, R. Pin, Y. Flammer, H. Lange, F. R. Eberli, B. Meier, Z. G. Turi, and O. M. Hess Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels N. Engl. J. Med., November 29, 2001; 345(22): 1593 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Garcia-Tevijano, C. Berasain, J. A. Rodriguez, F. J. Corrales, R. Arias, A. Martin-Duce, J. Caballeria, J. M. Mato, and M. A. Avila Hyperhomocysteinemia in Liver Cirrhosis: Mechanisms and Role in Vascular and Hepatic Fibrosis Hypertension, November 1, 2001; 38(5): 1217 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhou, J. Moller, C. C. Danielsen, J. Bentzon, H. B. Ravn, R. C. Austin, and E. Falk Dietary Supplementation With Methionine and Homocysteine Promotes Early Atherosclerosis but Not Plaque Rupture in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1470 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. TSUKAMOTO and S. C. LU Current concepts in the pathogenesis of alcoholic liver injury FASEB J, June 1, 2001; 15(8): 1335 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. J. Vermeulen, H. W. M. Niessen, M. Bogels, C. D. A. Stehouwer, J. A. Rauwerda, and V. W. M. van Hinsbergh Decreased Smooth Muscle Cell/Extracellular Matrix Ratio of Media of Femoral Artery in Patients With Atherosclerosis and Hyperhomocysteinemia Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 573 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J Riddell, A. Chisholm, S. Williams, and J. I Mann Dietary strategies for lowering homocysteine concentrations Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1448 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Manzi Systemic lupus erythematosus: a model for atherogenesis? Rheumatology, April 1, 2000; 39(4): 353 - 359. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fonseca, S. C. Guba, and L. M. Fink Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis Endocr. Rev., October 1, 1999; 20(5): 738 - 759. [Abstract] [Full Text]
|
|
|
|
|
|
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF]
|
|
|
|
|
|
M. D. Rekhter Collagen synthesis in atherosclerosis: too much and not enough Cardiovasc Res, February 1, 1999; 41(2): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ross Atherosclerosis -- An Inflammatory Disease N. Engl. J. Med., January 14, 1999; 340(2): 115 - 126. [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1833 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Kuller and R. W. Evans Homocysteine, Vitamins, and Cardiovascular Disease Circulation, July 21, 1998; 98(3): 196 - 199. [Full Text] [PDF]
|
|
|
|
|
|
V. S. Mujumdar, C. M. Tummalapalli, G. M. Aru, and S. C. Tyagi Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR Am J Physiol Cell Physiol, May 1, 2002; 282(5): C1009 - C1015. [Abstract] [Full Text] [PDF]
|
|